1. Home
  2. ANEB

as of 12-05-2025 4:00pm EST

$2.26
$0.11
-4.64%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Chart Type:
Time Range:
Founded: 2020 Country:
United States
United States
Employees: N/A City: LAKEWAY
Market Cap: 96.8M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 16.6K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.22 EPS Growth: N/A
52 Week Low/High: $0.80 - $3.42 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered ANEB Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 67.65%
67.65%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: